← feed

Is NCT03061734 results overdue?

Yes — results are overdue. Primary completion was 2018-02-08; the FDAAA-801 reporting deadline (2019-02-08) passed 2736 days ago and no results are posted on ClinicalTrials.gov.

Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine

NCT IDNCT03061734 ↗
SponsorAllodynic Therapeutics, Inc (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2018-02-08 (ACTUAL)
Reporting deadline2019-02-08 (completion + 365d)
Days overdue2736
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 c494ffdcfb8341dc… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03061734. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →